Zaheer A, Komel A, Abu Bakr M, Singh A, Saji A, Kharal M
Ann Med Surg (Lond). 2024; 86(8):4591-4600.
PMID: 39118774
PMC: 11305704.
DOI: 10.1097/MS9.0000000000002261.
Somerville E, Krohn L, Senkevich K, Yu E, Ahmad J, Asayesh F
Res Sq. 2024; .
PMID: 38883744
PMC: 11177962.
DOI: 10.21203/rs.3.rs-4425669/v1.
Goldstein J, McGlaughon J, Kanavy D, Goomber S, Pan Y, Deml B
Mol Genet Metab. 2023; 140(1-2):107715.
PMID: 37907381
PMC: 10872922.
DOI: 10.1016/j.ymgme.2023.107715.
Faro D, Losi V, Rodolico M, Torrisi E, Colomba P, Duro G
Genes (Basel). 2023; 14(9).
PMID: 37761944
PMC: 10531426.
DOI: 10.3390/genes14091804.
Belaramani K, Fung C, Kwok A, Lee S, Yau E, Luk H
Int J Neonatal Screen. 2023; 9(3).
PMID: 37606482
PMC: 10443280.
DOI: 10.3390/ijns9030045.
Patient centered guidelines for the laboratory diagnosis of Gaucher disease type 1.
Dardis A, Michelakakis H, Rozenfeld P, Fumic K, Wagner J, Pavan E
Orphanet J Rare Dis. 2022; 17(1):442.
PMID: 36544230
PMC: 9768924.
DOI: 10.1186/s13023-022-02573-6.
GALC variants affect galactosylceramidase enzymatic activity and risk of Parkinson's disease.
Senkevich K, Zorca C, Dworkind A, Rudakou U, Somerville E, Yu E
Brain. 2022; 146(5):1859-1872.
PMID: 36370000
PMC: 10151180.
DOI: 10.1093/brain/awac413.
An Overview of Molecular Mechanisms in Fabry Disease.
Amodio F, Caiazza M, Monda E, Rubino M, Capodicasa L, Chiosi F
Biomolecules. 2022; 12(10).
PMID: 36291669
PMC: 9599883.
DOI: 10.3390/biom12101460.
Evaluation of Strategies for Measuring Lysosomal Glucocerebrosidase Activity.
Ysselstein D, Young T, Nguyen M, Padmanabhan S, Hirst W, Dzamko N
Mov Disord. 2021; 36(12):2719-2730.
PMID: 34613624
PMC: 8853444.
DOI: 10.1002/mds.28815.
Narrative review on Morbus Fabry: diagnosis and management of cardiac manifestations.
Linhart A, Palecek T
Cardiovasc Diagn Ther. 2021; 11(2):650-660.
PMID: 33968642
PMC: 8102243.
DOI: 10.21037/cdt-20-593.
GM1 Gangliosidosis: Mechanisms and Management.
Rha A, Maguire A, Martin D
Appl Clin Genet. 2021; 14:209-233.
PMID: 33859490
PMC: 8044076.
DOI: 10.2147/TACG.S206076.
LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's disease.
Sosero Y, Yu E, Krohn L, Rudakou U, Mufti K, Ruskey J
Neurobiol Aging. 2021; 103:142.e1-142.e5.
PMID: 33781610
PMC: 8178224.
DOI: 10.1016/j.neurobiolaging.2021.02.018.
Longitudinal Measurements of Glucocerebrosidase activity in Parkinson's patients.
Alcalay R, Wolf P, Chiang M, Helesicova K, Zhang X, Merchant K
Ann Clin Transl Neurol. 2020; 7(10):1816-1830.
PMID: 32888397
PMC: 7545591.
DOI: 10.1002/acn3.51164.
Validation of dried blood spots in monitoring toxoplasmosis.
Hegazy M, Hegazy M, Azab M, Nabih N
Pathog Glob Health. 2020; 114(5):242-250.
PMID: 32419673
PMC: 7480522.
DOI: 10.1080/20477724.2020.1765125.
Comprehensive clinical, biochemical and genetic screening reveals four distinct genotypes as underlying variable manifestation of Gaucher disease in a single family.
Cullufi P, Tabaku M, Beetz C, Tomori S, Velmishi V, Gjikopulli A
Mol Genet Metab Rep. 2019; 21:100532.
PMID: 31709146
PMC: 6831897.
DOI: 10.1016/j.ymgmr.2019.100532.
SMPD1 mutations, activity, and α-synuclein accumulation in Parkinson's disease.
Alcalay R, Mallett V, Vanderperre B, Tavassoly O, Dauvilliers Y, Wu R
Mov Disord. 2019; 34(4):526-535.
PMID: 30788890
PMC: 6469643.
DOI: 10.1002/mds.27642.
Newborn screening in mucopolysaccharidoses.
Donati M, Pasquini E, Spada M, Polo G, Burlina A
Ital J Pediatr. 2018; 44(Suppl 2):126.
PMID: 30442156
PMC: 6238254.
DOI: 10.1186/s13052-018-0552-3.
Late-onset Pompe disease in France: molecular features and epidemiology from a nationwide study.
Semplicini C, Letard P, Antonio M, Taouagh N, Perniconi B, Bouhour F
J Inherit Metab Dis. 2018; 41(6):937-946.
PMID: 30155607
DOI: 10.1007/s10545-018-0243-7.
Alpha galactosidase A activity in Parkinson's disease.
Alcalay R, Wolf P, Levy O, Kang U, Waters C, Fahn S
Neurobiol Dis. 2018; 112:85-90.
PMID: 29369793
PMC: 5811339.
DOI: 10.1016/j.nbd.2018.01.012.
Muscle ultrasound: A useful tool in newborn screening for infantile onset pompe disease.
Hwang H, Hsu T, Lee Y, Wang H, Chiou H, Niu D
Medicine (Baltimore). 2017; 96(44):e8415.
PMID: 29095275
PMC: 5682794.
DOI: 10.1097/MD.0000000000008415.